We Acquires Leading Preclinical Services Provider T3 Labs1

We are excited to announce the acquisition of T3 Labs, a premier preclinical services provider known for its excellence in translational research and state-of-the-art laboratory capabilities. This strategic move enhances our ability to support early-stage medical device and pharmaceutical development, further expanding our expertise in preclinical testing and innovation. By integrating T3 Labs’ advanced facilities and experienced team into our operations, we’re committed to delivering even greater value to our clients and accelerating the journey from concept to clinic.